Literature DB >> 27121902

Infiltration of F98 glioma cells in Fischer rat brain is temporary stimulated by radiation.

Guillaume Desmarais1, Gabriel Charest2, Hélène Therriault1, Minghan Shi1, David Fortin3, Rachel Bujold1,4, David Mathieu2, Benoit Paquette1.   

Abstract

PURPOSE: Irradiation of brain stimulates the expression of inflammatory mediators, some of which can modify the ability of cancer cells to infiltrate the brain. In the present study, the time window during which this stimulation occurs was determined.
MATERIALS AND METHODS: Brain of Fischer rat was irradiated (15 Gy) and expression of pro-inflammatory mediators IL-1β, IL-6 and TNF-α was measured from 4 h to 20 days post-irradiation. Level of the matrix metalloproteinase 2 (MMP-2) and prostaglandin E2 (PGE2) which can favor cancer cell infiltration were also measured. The F98 glioma cells were implanted either during (4 h post-irradiation) or after (10 days post-irradiation) the pro-inflammatory phase. Infiltration distance of F98 cells in brain parenchyma and the median survival time of the animals were determined.
RESULTS: Expression of IL-1β, IL-6 and TNF-α was significantly increased in the irradiated brains with a peak at 4 h post-irradiation. Implantation of F98 glioma cells 4 h post-irradiation reduced the median survival time of Fischer rats to 18 days, compared to 25 days when the F98 were implanted in non-irradiated brain. Irradiation of the brain increased the distance of infiltration of F98 cells and was associated with increased levels of MMP-2 and PGE2. Conversely, F98 cells implanted 10 days post-irradiation have infiltrated the brain over a shorter distance and the median survival time of rats was increased to 35 days.
CONCLUSIONS: Cancer recurrence is frequently observed in GBM patients. A better understanding of the inflammatory response observed in irradiated brain could contribute to develop new therapeutic modalities to further increase the efficiency of radiotherapy.

Entities:  

Keywords:  Brain cancer; cytokines; glioblastoma multiforme; infiltration; inflammation; radiation treatment

Mesh:

Year:  2016        PMID: 27121902     DOI: 10.1080/09553002.2016.1175682

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  6 in total

1.  Response to "Glioma resection and tumor recurrence: back to Semmelweis".

Authors:  Philippe Menei; Anne Clavreul; Jean Michel Lemée
Journal:  Neuro Oncol       Date:  2016-10-07       Impact factor: 12.300

2.  Late Effects of Radiation Prime the Brain Microenvironment for Accelerated Tumor Growth.

Authors:  Chong Duan; Ruimeng Yang; Liya Yuan; John A Engelbach; Christina I Tsien; Keith M Rich; Sonika M Dahiya; Tanner M Johanns; Joseph J H Ackerman; Joel R Garbow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-08-30       Impact factor: 7.038

Review 3.  Drug Delivery Systems in the Development of Novel Strategies for Glioblastoma Treatment.

Authors:  Wiam El Kheir; Bernard Marcos; Nick Virgilio; Benoit Paquette; Nathalie Faucheux; Marc-Antoine Lauzon
Journal:  Pharmaceutics       Date:  2022-06-01       Impact factor: 6.525

4.  Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model.

Authors:  Falko Lange; Jens Hartung; Clara Liebelt; Julius Boisserée; Tobias Resch; Katrin Porath; Julia Hörnschemeyer; Gesine Reichart; Tina Sellmann; Valentin Neubert; Stephan Kriesen; Guido Hildebrandt; Elisabeth Schültke; Rüdiger Köhling; Timo Kirschstein
Journal:  Front Neurosci       Date:  2020-11-30       Impact factor: 4.677

5.  Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.

Authors:  Richard E Kast; Nicolas Skuli; Georg Karpel-Massler; Guido Frosina; Timothy Ryken; Marc-Eric Halatsch
Journal:  Oncotarget       Date:  2017-06-01

Review 6.  STAT3 Contributes to Radioresistance in Cancer.

Authors:  Xuehai Wang; Xin Zhang; Chen Qiu; Ning Yang
Journal:  Front Oncol       Date:  2020-07-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.